Celldex Therapeutics shares owned by Mirador Capital Partners
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Mirador Capital Partners
from 13F filings
Historical chart of Mirador Capital Partners investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Mirador Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Mirador Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $4.4M | 105k | 41.97 |
| 2023-12-31 | $4.3M | 108k | 39.66 |
| 2023-09-30 | $3.0M | 108k | 27.52 |
| 2023-06-30 | $3.6M | 105k | 33.93 |
| 2023-03-31 | $3.6M | 101k | 35.98 |
| 2022-12-31 | $4.7M | 106k | 44.57 |
| 2022-09-30 | $3.0M | 107k | 28.11 |
| 2022-06-30 | $2.9M | 106k | 26.96 |
| 2022-03-31 | $3.1M | 90k | 34.06 |
| 2021-12-31 | $3.3M | 86k | 38.64 |
| 2021-09-30 | $4.0M | 74k | 53.99 |
| 2021-06-30 | $2.6M | 79k | 33.44 |
| 2021-03-31 | $1.6M | 76k | 20.60 |
| 2020-12-31 | $469k | 27k | 17.53 |
| 2020-09-30 | $378k | 26k | 14.84 |
| 2020-06-30 | $249k | 19k | 13.01 |
| 2020-03-31 | $27k | 11k | 2.38 |